Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As H1N1 Virus Spreads Fast In India, Government Ups Its Offensive

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - India's health ministry has gone into hyperactive mode to combat the spread of the A/H1N1 influenza virus. The disease has claimed 14 lives over the last five days, while close to 1,000 more people tested positive and were treated in government-run hospitals

You may also be interested in...



With Shortage Looming Large, Cipla Offers Generic Tamiflu, Relenza To U.S. Health Department

MUMBAI - Known for supplying low-priced anti-retroviral cocktail therapy to frontline African nations to combat the spread of HIV/AIDS, Cipla - India's largest drug maker by market share - is in discussions with U.S. health agencies to boost production of antiviral oseltamivir, the generic for Roche's Tamiflu for treating the rapidly spreading H1N1 virus

With Shortage Looming Large, Cipla Offers Generic Tamiflu, Relenza To U.S. Health Department

MUMBAI - Known for supplying low-priced anti-retroviral cocktail therapy to frontline African nations to combat the spread of HIV/AIDS, Cipla - India's largest drug maker by market share - is in discussions with U.S. health agencies to boost production of antiviral oseltamivir, the generic for Roche's Tamiflu for treating the rapidly spreading H1N1 virus

Roche In Stand-by Mode To Supply Tamifl& To Indian Government; Others Queue Up Too

MUMBAI - As the Indian government grapples with the threat of influenza H1N1 through countrywide moves to stockpile drugs, protective masks and diagnostic kits, Roche India has said it has been approached for supplies of Tamiflu (oseltamivir) by the Indian health ministry but there are no clear orders issued yet to commence supply of the drugs

UsernamePublicRestriction

Register

OM003387

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel